Related Experiment Videos
[Schoenlein-Henoch syndrome in adults--current aspects]
C de Pree1, J A Schifferli, I Masouye
1Clinique médicale, Hôpital cantonal universitaire de Genève.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|August 30, 1994
Summary
Schoenlein-Henoch purpura, an IgA-vasculitis, presents with rash and can affect the gut, joints, and kidneys. Adult renal involvement is severe and impacts disease outcomes.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Schoenlein-Henoch purpura (SHP) is a clinical syndrome characterized by palpable purpura, primarily on the legs.
- It involves gastrointestinal, articular, and renal systems, with renal involvement often being more severe in adults and dictating prognosis.
Purpose of the Study:
- To review the current understanding of Schoenlein-Henoch purpura.
- To discuss its anatomical-clinical features, therapeutic strategies, and etiopathogenic aspects.
Main Methods:
- Literature review of anatomo-clinical, therapeutic, and etiopathogenic aspects of SHP.
- Synthesis of current knowledge on IgA vasculitis.
Main Results:
- SHP is an IgA vasculitis potentially triggered by various antigenic factors.
- Pathogenesis involves demonstrated IgA immune system dysfunction.
- Renal involvement severity in adults significantly influences disease outcome.
Conclusions:
- Schoenlein-Henoch purpura requires comprehensive understanding of its multifaceted clinical presentations.
- Further research into IgA immune system dysfunction is crucial for targeted therapies.
- Adults with SHP necessitate vigilant renal monitoring due to higher risk of severe outcomes.